Accuzide Filmtabletten and Accuzide forte Filmtabletten

Recall | Medicines | 08/03/2022

The marketing authorisation holder informed its customers on March 07, 2022, that the nitrosamine levels of the listed batches are above the permitted acceptable daily dose.

For that reason, the affected batches are recalled as a precautionary measure.

Name of the medicinal product 1) Accuzide Filmtabletten
2) Accuzide forte Filmtabletten
Marketing authorisation number(s) 1) 1-20206
2) 1-20208
CIP code 1) 1276810
2) 1276827
Marketing authorisation holder Pfizer Corporation Austria GmbH
Batch number(s) 1) Batch, Expiry Date
DK4164, 31.10.2022
DT1721, 31.10.2022
FK8589, 31.07.2023

2) Batch, Expiry Date
CK1702, 30.04.2022
ET1542, 31.10.2022
FM6658, 31.08.2024
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-3795

Further inquiry note